미국의 환자 체온 관리 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 용도별, 최종 용도별, 부문별 예측(2025-2033년)

U.S. Patient Temperature Management Market Summary

The U.S. patient temperature management market size was estimated at USD 1.39 billion in 2024 and is projected to reach USD 2.66 billion by 2033, growing at a CAGR of 7.55% from 2025 to 2033. The market is substantially growing due to increased surgical procedures.

This surge is attributed to several factors, including advancements in medical technology, an aging population, an increasing number of hypothermia cases, and an increasing prevalence of chronic diseases requiring surgical intervention. For instance, In January 2024, the Population Reference Bureau estimated that the number of Americans aged 65 and above would grow significantly, reaching 82 million by 2050, up from 58 million in 2022. In addition, the proportion of this age group in the total population is projected to rise from 17% to 23%. Overall, the rise in the number of surgical procedures, coupled with the growing emphasis on patient safety and outcomes, is fueling the market growth.

The rising incidence of cancer and the complexity of treatment protocols are key drivers of the patient temperature management industry. Patients undergoing chemotherapy or radiation often experience disrupted thermoregulation due to immune suppression or treatment side effects. In some cases, temperature modulation is used therapeutically. Hyperthermia, or thermotherapy, involves heating body tissues up to 113°F to destroy cancer cells while minimizing damage to healthy tissue. In May 2025, according to the National Cancer Institute, the U.S. is projected to witness around 2.04 million new cancer diagnoses and over 618,000 deaths. Breast, prostate, and lung cancers are expected to remain the most prevalent. Despite the high burden, cancer death rates have steadily declined since the 1990s, with annual decreases of 1.7% in men and 1.3% in women reported between 2018 and 2022.

Temperature management is also critical in cardiovascular procedures, where maintaining normothermia helps reduce complications and improve recovery. Cardiac surgeries and catheter-based interventions often require controlled temperature environments to stabilize metabolism, reduce ischemic injury, and support hemodynamics. In October 2024, according to the CDC, heart disease remained the leading cause of death in the U.S., responsible for over 919000 deaths in 2023, roughly 1 in every 3. It affects people across all racial and ethnic groups, with coronary artery disease being the most common type. The growing prevalence of cardiovascular disease and increased use of minimally invasive procedures are driving demand for advanced temperature management systems in surgical and interventional settings.

Strategic partnerships and distribution agreements are expanding access to temperature management technologies. In January 2024, SourceMark announced a renewed partnership with Gentherm Medical, a leading manufacturer of temperature control systems. Through this agreement, SourceMark became the primary U.S. distributor for Gentherm's specialized patient warming products. This collaboration reflects a broader industry trend toward improving product availability and clinical outcomes in surgical, critical care, and oncology applications.

U.S. Patient Temperature Management Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. patient temperature management market report based on type, application, end use, and region:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Patient Warning Systems
• Conventional Warning Systems
• Surface Warning Systems
• Others
  • Open-basin
  • Fluid Warmers
• Patient Cooling Systems
• Conventional Cooling Systems
• Surface Cooling Systems
• Others
• Dual Technology
• Surface Warming Systems
• Intravascular Warming Systems
• Consumables
• Irrigation Drapes
• Fluid Warmer Drapes
• Scope Warmer Drapes
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• General Surgery
• Cardiology
• Pediatrics
• Neurology
• Orthopedic Surgery
• Thoracic Surgery
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Operating rooms
• Neonatal ICU
• ICUs
• Emergency room
• Preoperative Care Units
• Postoperative Care Units
• Acute Care
• Burn Centers
• Cath Labs
• Neurological Care Units
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Patient Temperature Management Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenges analysis
• 3.3. U.S. Patient Temperature Management: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Technology Landscape

Chapter 4. U.S. Patient Temperature Management Market Segment Analysis, By Type, 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Type Market Share Analysis, 2024 & 2033
• 4.3. Segment Dashboard
• 4.4. U.S. Patient Temperature Management Market, by Type, 2021 to 2033
• 4.5. Patient Warming Systems
  • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.5.1.1. Conventional Warming Systems
      • 4.5.1.1.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.5.1.2. Surface Warming Systems
      • 4.5.1.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.5.1.3. Others
      • 4.5.1.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.6. Patient Cooling Systems
  • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.1.1. Conventional Cooling Systems
      • 4.6.1.1.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.1.2. Surface Cooling Systems
      • 4.6.1.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.6.1.3. Others
      • 4.6.1.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.7. Dual Technology
  • 4.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.7.1.1. Surface Systems
      • 4.7.1.1.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.7.1.2. Intravascular Systems
      • 4.7.1.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.8. Consumables
  • 4.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.8.1.1. Irrigation Drapes
      • 4.8.1.1.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.8.1.2. Fluid Warmer Drapes
      • 4.8.1.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
    • 4.8.1.3. Scope Warmer Drapes
      • 4.8.1.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. U.S. Patient Temperature Management Market Segment Analysis, By Application, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. Application Market Share Analysis, 2024 & 2033
• 5.3. Segment Dashboard
• 5.4. U.S. Patient Temperature Management Market, by Application, 2021 to 2033
• 5.5. General Surgery
  • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.6. Cardiology
  • 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. Pediatrics
  • 5.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.8. Neurology
  • 5.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.9. Orthopedic Surgery
  • 5.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.10. Thoracic Surgery
  • 5.10.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.11. Others
  • 5.11.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. U.S. Patient Temperature Management Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

• 6.1. Definition and Scope
• 6.2. End Use Market Share Analysis, 2024 & 2033
• 6.3. Segment Dashboard
• 6.4. U.S. Patient Temperature Management Market, by End Use, 2021 to 2033
• 6.5. Operating Rooms
  • 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.6. Neonatal ICU
  • 6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.7. ICUs
  • 6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.8. Emergency Rooms
  • 6.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.9. Postoperative Care Units
  • 6.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.10. Preoperative Care Units
  • 6.10.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.11. Acute Care
  • 6.11.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.12. Burn Centers
  • 6.12.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.13. Cath Labs
  • 6.13.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.14. Neurological Care Units
  • 6.14.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.15. Others
  • 6.15.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Profiles
  • 7.3.1. Stryker Corporation
    • 7.3.1.1. Company overview
    • 7.3.1.2. Financial performance
    • 7.3.1.3. Product benchmarking
    • 7.3.1.4. Strategic initiatives
  • 7.3.2. Zoll Medical Corporation
    • 7.3.2.1. Company overview
    • 7.3.2.2. Financial performance
    • 7.3.2.3. Product benchmarking
    • 7.3.2.4. Strategic initiatives
  • 7.3.3. Medtronic
    • 7.3.3.1. Company overview
    • 7.3.3.2. Financial performance
    • 7.3.3.3. Product benchmarking
    • 7.3.3.4. Strategic initiatives
  • 7.3.4. Bard Medical
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Cincinnati Sub-Zero Products, Llc
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. 3M Company
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Pintler Medical
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. ECOLAB INC.
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives